Page 5 - U.S. Pharmaceuticals & Biotech Stocks - Top Gainers Today

Company	Last Price	1D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
DNLI Denali Therapeutics	US$24.68	0.7%	34.7%	US$3.5b	US$42.08	PB2.7x	E25.6%	n/a
PHVS Pharvaris	US$24.17	2.0%	36.9%	US$1.3b	US$34.70	PB4.2x	E10.1%	n/a
IMTX Immatics	US$7.80	2.8%	-7.1%	US$905.9m	US$16.75	PS7.7x	E-22.8%	n/a
VIR Vir Biotechnology	US$7.62	2.4%	-20.6%	US$1.0b	US$29.50	PS13.3x	E1.0%	n/a
OCS Oculis Holding	US$15.37	3.9%	59.8%	US$620.4m	US$28.42	PS658.8x	E-4.7%	n/a
ARDX Ardelyx	US$5.35	1.9%	22.4%	US$1.3b	US$10.67	PS5x	E69.6%	n/a
IMNM Immunome	US$11.53	3.4%	50.3%	US$695.9m	US$30.00	PS71.1x	E19.9%	n/a
RVNC Revance Therapeutics	US$4.02	5.8%	-43.1%	US$398.6m	US$9.23	PS1.6x	E70.6%	n/a
BIOA BioAge Labs	US$19.70	3.3%	n/a	US$683.6m	US$42.33	PB2.3x	E-15.6%	n/a
DVAX Dynavax Technologies	US$12.66	1.4%	-4.7%	US$1.6b	US$24.60	PE81.3x	E39.4%	n/a
RARE Ultragenyx Pharmaceutical	US$47.36	0.5%	23.1%	US$4.3b	US$92.43	PS8.4x	E54.2%	n/a
THRD Third Harmonic Bio	US$12.93	3.9%	66.8%	US$560.5m	US$19.00	PB2x	E-28.4%	n/a
MRSN Mersana Therapeutics	US$2.17	8.5%	41.8%	US$247.1m	US$6.50	PS7.7x	E6.6%	n/a
OMER Omeros	US$12.15	3.1%	489.8%	US$683.2m	n/a	PE-3.8x	E39.1%	n/a
ISEE IVERIC bio	US$39.95	0.4%	236.3%	US$5.5b	US$40.00	PB11.6x	E59.0%	n/a
IDYA IDEAYA Biosciences	US$26.78	0.9%	-13.2%	US$2.3b	US$54.87	PS590.2x	E8.9%	n/a
MDXG MiMedx Group	US$9.23	1.5%	17.0%	US$1.3b	US$13.00	PE17.1x	E-1.9%	n/a
ANNX Annexon	US$5.29	3.7%	105.8%	US$543.6m	US$15.00	PB1.7x	E35.6%	n/a
EXEL Exelixis	US$36.45	0.2%	73.2%	US$10.4b	US$31.83	PE22.3x	E15.6%	n/a
DMAC DiaMedica Therapeutics	US$5.08	10.0%	89.6%	US$197.6m	US$7.00	PB4.5x	E-11.3%	n/a
HUMA Humacyte	US$4.43	3.5%	70.4%	US$550.7m	US$13.00	PE-3.7x	E68.9%	n/a
RNAC Cartesian Therapeutics	US$18.65	4.1%	-42.2%	US$455.2m	US$40.25	PS9.9x	E5.2%	n/a
ADCT ADC Therapeutics	US$2.22	9.4%	204.1%	US$196.3m	US$8.40	PS3x	E21.3%	n/a
KNSA Kiniksa Pharmaceuticals International	US$22.04	1.1%	40.4%	US$1.6b	US$36.00	PS4.1x	E58.9%	n/a